# Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

> **NCT00550589** · PHASE2 · COMPLETED · sponsor: **AIDS Malignancy Consortium** · enrollment: 33 (actual)

## Conditions studied

- Anal Cancer
- Precancerous Condition

## Interventions

- **DRUG:** cidofovir
- **GENETIC:** DNA methylation analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** polymerase chain reaction
- **PROCEDURE:** biopsy
- **PROCEDURE:** histopathologic examination

## Key facts

- **NCT ID:** NCT00550589
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-12-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550589, "Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00550589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*